Pharmaco - Press Releases

Date	Title	Company
20-Jan-2022	VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis	Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
20-Jan-2022	Optimer® diagnostic reagent detects omicron variant	Aptamer Group
20-Jan-2022	Parse Biosciences Announces Partnership With Research Instruments Group to Offer RNA-Seq Kits in Singapore and Southeast Asia Region	Parse Biosciences
20-Jan-2022	Refeyn’s new SamuxMP mass photometer promises to significantly improve AAV workflows	Refeyn
20-Jan-2022	Vetter’s New Clinical Manufacturing Site Now Officially Authorized	Vetter
20-Jan-2022	The Lancet Neurology reports impact of daridorexant on both nighttime symptoms and daytime functioning in adults with insomnia	Idorsia Ltd
20-Jan-2022	Transgene and BioInvent Joint JITC Publication Demonstrates the Potential of BT-001 Oncolytic Virus to provide therapeutic benefit beyond current anti-PD1/ anti-CTLA-4 immune checkpoint blockade	Transgene
20-Jan-2022	UAB announces first clinical-grade transplant of gene-edited pig kidneys into brain-dead human	UAB
20-Jan-2022	F-star Announces Issuance of U.S. Patent Protecting FS118, a Bispecific Antibody Targeting PD-L1 and LAG-3	F-star Therapeutics, Inc.
20-Jan-2022	Takeda Named Global Top Employer for Fifth Consecutive Year	Takeda
20-Jan-2022	Cassiopea SpA announces preparing delisting of shares on SIX Swiss Exchange	Cassiopea S.p.A.
20-Jan-2022	Kuros Biosciences publishes first-in-human clinical data for Fibrin-PTH (KUR-113) in treatment of open tibial shaft fractures	Kuros Biosciences AG
20-Jan-2022	Medacta Group SA reports strong revenue growth of 21.4% in 2021	Medacta Group SA
20-Jan-2022	Zur Rose Group: steady growth in a volatile market environment	Zur Rose Group AG
19-Jan-2022	Vetter’s New Clinical Manufacturing Site Now Officially Authorized	B3C newswire
19-Jan-2022	PHARMACEUTICAL INDUSTRY SETS OUT ITS MANIFESTO FOR THE NEXT NORTHERN IRELAND ASSEMBLY	ABPI
19-Jan-2022	Cosette Pharmaceuticals Acquires Rights to Eight Branded Products from Daiichi Sankyo	Cosette Pharmaceuticals
19-Jan-2022	Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook	Bone Therapeutics
19-Jan-2022	Transgene and PersonGen Announce Collaboration to Evaluate a New Combination Therapy Against Solid Tumors	Transgene
19-Jan-2022	PharmaLex merger with MAP Group expands integrated market access expertise	PharmaLex